SARAJEVO (Bosnia and Herzegovina), February 4 (SeeNews) â Luxembourg-based Haden sold on Tuesday its 15.95% stake in Bosnian drug maker Bosnalijek [SAJ:BSNLR] for 18.8 million marka ($10.6 million/9.6 million euro), Sarajevo Stock Exchange (SASE) data showed.